| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_678307dacb9fec41911d1013679d5d5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a694cf482a929cd1d116cc0c71bf3760 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18 |
| filingDate |
2008-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be5fee1028bedfcf475bbb8e1ab3f052 |
| publicationDate |
2009-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009083211-A2 |
| titleOfInvention |
Pharmaceutical compound for the prophylaxis and/or symptomatic treatment of cystic fibrosis |
| abstract |
The invention relates to a pharmaceutical compound for the prophylaxis and/or symptomatic treatment of cystic fibrosis, particularly for the prophylaxis and/or treatment of infections and/or infection illnesses manifesting with cystic fibrosis, having at least one anti-depressive and preferable at least one dispersion agent and/or at least one pharmaceutically tolerated carrier material. |
| priorityDate |
2007-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |